2025-07-14 - Analysis Report
Okay, here's an analysis of Hims & Hers Health Inc (HIMS), based on the data you provided.  The report is structured as requested.

**Hims & Hers Health Inc (HIMS) Stock Analysis**

**1. Relative Performance vs. S&P 500 (VOO)**

*   **Ticker:** HIMS
*   **Company Overview:** Hims & Hers Health Inc is a telehealth company that provides personalized health and wellness solutions directly to consumers.

**Key Performance Numbers:**

*   **HIMS Cumulative Return:** 181.13%
*   **VOO (S&P 500) Cumulative Return:** 64.05%
*   **Absolute Divergence (HIMS - VOO):** 117.08%
*   **Divergence Range (Max: 288.9, Min: -88.4):**
    *   **Relative Divergence:** 54.5%

**Analysis of Relative Performance:**

HIMS has significantly outperformed the S&P 500 (VOO) over the period examined. The current divergence of 117.08% indicates a strong outperformance. However, the relative divergence of 54.5% suggests that while HIMS is currently outperforming, it's positioned in the middle of its historical divergence range relative to VOO. This implies that while the performance is strong, there's still room for both further outperformance or potential convergence towards the S&P 500's returns.

**Alpha and Beta Analysis**

| Year      | CAGR    | MDD     | Alpha  | Beta  | Cap(B) |
| :---------- | :------ | :------ | :----- | :---- | :----- |
| 2019-2021 | -46.0%  | 51.0%   | -84.0% | -0.0  | 1.5    |
| 2020-2022 | -15.0%  | 72.1%   | -17.0% | -0.0  | 1.4    |
| 2021-2023 | -51.0%  | 72.1%   | -69.0% | -0.1  | 2.0    |
| 2022-2024 | 127.0% | 78.4%   | 101.0% | -0.1  | 5.5    |
| 2023-2025 | 176.0% | 78.4%   | 129.0% | -0.1  | 10.8   |

**Analysis of Alpha and Beta:**

*   **CAGR (Compound Annual Growth Rate):**  CAGR shows significant fluctuation over different periods, with large negative values in early periods and substantial positive values in recent periods. This suggests a volatile growth trajectory for HIMS.
*   **MDD (Maximum Drawdown):**  The consistently high MDD values indicate substantial risk and volatility in HIMS, with investors experiencing significant declines from peak values.
*   **Alpha:**  The alpha values are highly variable, with large negative alpha in earlier periods and substantial positive alpha in later periods. This reflects periods of significant underperformance relative to the market followed by strong outperformance.
*   **Beta:**  The beta values are consistently negative and close to zero, suggesting that HIMS has a weak or inverse relationship with the broader market. This could indicate that HIMS is relatively insulated from market movements or that it moves in the opposite direction of the market.
*   **Cap (Market Capitalization):** The market capitalization of HIMS has grown significantly over the periods analyzed, indicating increasing investor confidence and valuation as the company matures.

**2. Recent Stock Price Action**

*   **Current Price:** 47.89
*   **Last Market Data:** {'price': 48.42, 'previousClose': 47.89, 'change': 1.11}
*   **5-Day Moving Average:** 49.36
*   **20-Day Moving Average:** 50.94
*   **60-Day Moving Average:** 48.50

**Analysis:**

The stock price closed at 47.89 but the "Last Market" data suggests a recent tick upwards to 48.42 with a change of 1.11. The 5-day and 20-day moving averages are above the current price, suggesting potential short-term downward pressure. The 60-day moving average is slightly above the current price, providing a closer support level. The recent positive change indicates a potential rebound, but it needs to be sustained.

**3. Technical Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.3294 (Low Risk)
*   **RSI (Relative Strength Index):** 31.14
*   **PPO (Percentage Price Oscillator):** -0.23
*   **Hybrid Signal:** cash_69%_Sell 1.2% of holdings (15 shares - Caution - MRI:0.34)
*   **20-Day Relative Divergence Change:** +0.2 (Short-term increase)
*   **Expected Return:** -16.6% (Long-term vs. S&P 500)

**Analysis:**

*   **MRI:** The MRI is classified as low risk, suggesting a stable market environment, or that HIMS is behaving with relatively low risk.
*   **RSI:** The RSI of 31.14 indicates that the stock is approaching oversold conditions, which could suggest a potential buying opportunity.
*   **PPO:** The negative PPO indicates that the short-term moving average is below the long-term moving average, suggesting a potential downward trend.
*   **Hybrid Signal:** The hybrid signal suggests a cautious approach, recommending a high cash position and a small reduction in holdings. This is influenced by the low MRI but also reflects the current technical picture.
*   **Recent Divergence Change:** The short-term increase in relative divergence indicates some positive momentum.
*   **Expected Return:** The negative expected return suggests that HIMS is projected to underperform the S&P 500 over the long term if bought at the current levels, meaning that long-term returns are worse compared to the index.

**4. Recent News & Significant Events**

*   **[2025-07-13]:** HIMS has recently made headlines due to major business developments, regulatory changes, or market events.
*   **[2025-07-12]:** Analysts are discussing HIMS's recent performance and its outlook in the context of industry trends and global economic factors.
*   **[2025-07-11]:** HIMS's stock has shown notable volatility, influenced by recent news, earnings reports, or executive actions.
*   **[2025-07-14]:** Market experts highlight both risks and opportunities for HIMS, advising investors to monitor recent news and company announcements.

**Analysis:**

The news suggests that HIMS is experiencing significant events that are influencing its stock performance. This volatility and uncertainty require careful monitoring of news and announcements. Analyst discussions and market expert opinions highlight both potential opportunities and risks.

**5. Recent Earnings Analysis:**

| 날짜       | EPS  | 매출     |
| :--------- | :--- | :------- |
| 2025-05-05 | 0.22 | 0.59 B$  |
| 2024-11-04 | 0.35 | 0.40 B$  |
| 2024-08-05 | 0.06 | 0.32 B$  |
| 2024-05-06 | 0.05 | 0.28 B$  |
| 2025-05-05 | 0.05 | 0.28 B$  |

**Analysis:**

The earnings data reveals increasing EPS values in recent quarters, suggesting improved profitability. The revenue also shows a clear upward trend, indicating growth in the company's business. The consistent growth in both EPS and revenue is a positive sign. However, there seems to be a duplicate entry for 2025-05-05.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
| :----------- | :-------- | :------------ |
| 2025-03-31   | $0.59B    | 73.50%        |
| 2024-12-31   | $0.48B    | 76.81%        |
| 2024-09-30   | $0.40B    | 79.16%        |
| 2024-06-30   | $0.32B    | 81.30%        |
| 2024-03-31   | $0.28B    | 82.36%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE      |
| :----------- | :-------- | :------- |
| 2025-03-31   | $0.55B    | 9.01%    |
| 2024-12-31   | $0.48B    | 5.46%    |
| 2024-09-30   | $0.44B    | 17.18%   |
| 2024-06-30   | $0.36B    | 3.67%    |
| 2024-03-31   | $0.34B    | 3.23%    |

**Analysis:**

*   **Revenue and Profitability:** Revenue is steadily increasing, indicating robust sales growth. However, the profit margin has decreased, from 82.36% in Q1 2024 to 73.50% in Q1 2025.
*   **Capital and Profitability:** Equity is increasing, reflecting the company's ability to retain earnings and raise capital. The ROE (Return on Equity) is volatile but shows a significant peak at 17.18% in Q3 2024.

**7. Overall Summary and Analysis**

Hims & Hers Health Inc (HIMS) presents a mixed picture:

*   **Strengths:** HIMS has significantly outperformed the S&P 500, demonstrating its potential for high growth. Recent earnings and revenue data shows strong positive trends. Equity is also on the rise.
*   **Weaknesses:** The stock exhibits high volatility, as indicated by the large MDD and the conflicting signals of the PPO/RSI. Also, the current decrease in profit margin and negative expectation return should be noted.
*   **Opportunities:** The company is operating in a growing telehealth market.
*   **Threats:** Market volatility and regulatory changes (as highlighted by recent news) could impact the stock.

**Recommendation:**

Given the mixed signals, a cautious approach is warranted. While HIMS has shown impressive growth and outperformed the market, the high volatility and negative expected return suggest that investors should carefully monitor the company's performance, market conditions, and news. The hybrid signal recommending a high cash position and a small reduction in holdings seems prudent. Long-term investors should be aware of the potential for underperformance relative to the S&P 500.
